These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


254 related items for PubMed ID: 15081564

  • 1. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
    Ueshima S, Fukao H, Okada K, Matsuo O.
    Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
    [Abstract] [Full Text] [Related]

  • 2. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H, Hagiya Y, Ueshima S, Okada K, Takaishi T, Izaki S, Matsuo O.
    Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
    [Abstract] [Full Text] [Related]

  • 3. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F, D'Alessio S, Serratì S, Pucci M, Del Rosso A, Benelli R, Ferrari N, Noonan DM, Albini A, Fibbi G, Del Rosso M.
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [Abstract] [Full Text] [Related]

  • 4. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM, Grenett HE, Benza RL, Abou-Agag LH, Tresnak JK, Wheeler CG, Booyse FM.
    Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
    [Abstract] [Full Text] [Related]

  • 5. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR, Silence J, Lemmens G, Frederix L, Collen D.
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [Abstract] [Full Text] [Related]

  • 6. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T, Kikuchi H, Ikeda T, Okamoto Y, Hamanishi C, Tanaka S.
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [Abstract] [Full Text] [Related]

  • 7. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
    Fibbi G, Caldini R, Chevanne M, Pucci M, Schiavone N, Morbidelli L, Parenti A, Granger HJ, Del Rosso M, Ziche M.
    Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
    [Abstract] [Full Text] [Related]

  • 8. Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice.
    Jögi A, Pass J, Høyer-Hansen G, Lund LR, Nielsen BS, Danø K, Rømer J.
    J Thromb Haemost; 2007 Sep; 5(9):1936-44. PubMed ID: 17723133
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
    Lijnen HR, Wagner EF, Collen D.
    Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
    [Abstract] [Full Text] [Related]

  • 10. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.
    Fibbi G, Pucci M, Grappone C, Pellegrini G, Salzano R, Casini A, Milani S, Del Rosso M.
    Hepatology; 1999 Mar; 29(3):868-78. PubMed ID: 10051491
    [Abstract] [Full Text] [Related]

  • 11. Control of the chondrocyte fibrinolytic balance by the drug piroxicam: relevance to the osteoarthritic process.
    Fibbi G, Serni U, Matucci A, Mannoni A, Pucci M, Anichini E, Del Rosso M.
    J Rheumatol; 1994 Dec; 21(12):2322-8. PubMed ID: 7699636
    [Abstract] [Full Text] [Related]

  • 12. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
    Odekon LE, Blasi F, Rifkin DB.
    J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.
    Chen Y, Budd RC, Kelm RJ, Sobel BE, Schneider DJ.
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1777-83. PubMed ID: 16709941
    [Abstract] [Full Text] [Related]

  • 14. Native atherosclerosis and vein graft arterialization: association with increased urokinase receptor expression in vitro and in vivo.
    Okada SS, Golden MA, Raghunath PN, Tomaszewski JE, David ML, Kuo A, Kariko K, Barnathan ES.
    Thromb Haemost; 1998 Jul; 80(1):140-7. PubMed ID: 9684800
    [Abstract] [Full Text] [Related]

  • 15. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
    Fibbi G, D'Alessio S, Pucci M, Cerletti M, Del Rosso M.
    Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration.
    Cullen JP, Nicholl SM, Sayeed S, Sitzmann JV, Okada SS, Cahill PA, Redmond EM.
    Thromb Res; 2004 Jan; 114(1):57-65. PubMed ID: 15262486
    [Abstract] [Full Text] [Related]

  • 17. Urokinase (u-PA) is produced by collecting duct principal cells and is post-transcriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.
    Piedagnel R, Tiger Y, Lelongt B, Ronco PM.
    J Cell Physiol; 2006 Feb; 206(2):394-401. PubMed ID: 16155905
    [Abstract] [Full Text] [Related]

  • 18. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.
    Schaefer U, Vorlova S, Machida T, Melchor JP, Strickland S, Levi R.
    J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057
    [Abstract] [Full Text] [Related]

  • 19. Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells.
    Oszajca K, Bieniasz M, Brown G, Swiatkowska M, Bartkowiak J, Szemraj J.
    Biochem Cell Biol; 2008 Dec; 86(6):477-86. PubMed ID: 19088796
    [Abstract] [Full Text] [Related]

  • 20. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
    Zhang G, Cai X, López-Guisa JM, Collins SJ, Eddy AA.
    J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.